Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose titrated morphine for dyspnea relief in intensive care patients with acute respiratory failure
2019-003091-39Phase 2Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in acute respiratory decompensation comparing Low-dose titrated morphine with Placebo (2 arms). Primary endpoint: Average dyspnea over 24 hours. Started Nov 2019; status: completed.
02
Drugs
morphine
03
Conditions
acute respiratory decompensation
Beyond the preview
Go deeper on 2019-003091-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-003091-39.